Asia
Europe, Middle East, Africa
North America
bioMérieux Corporate Website | Pioneering diagnostics
bioMérieux acquires a majority stake in Hybiome
Specialized in automated immunoassay tests, Hybiome develops, manufactures and markets a complete range of diagnostic solutions cleared by the China Food and Drug Administration. Thanks to this acquisition, we strengthen our presence both in China and in the immunoassay market.
ENDOZYME® II GO Innovation Awards 2018
Our test for the detection of endotoxins in pharmaceutical microbiology control, ENDOZYME® II GO, has been shortlisted as one of the winners in the Medicine Maker Innovation Awards 2018. These awards recognize innovative technologies launched in 2018 to support pharma development and manufacturing.
Read more about ENDOZYME® II GO >>